By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.

Reject
United Kingdom | EnglishEN

Current country and language: United KingdomUnited Kingdom | English (EN)

ChinaChina
GermanyGermany
IrelandIreland
ItalyItaly
SpainSpain
United KingdomUnited Kingdom

YOU ARE LEAVING THE CURRENT LANGUAGE


Oncology
products

Alliance’s oncology products include treatments for certain types of cancers such as ImmuCyst® (BCG immunotherapy) for non-muscle invasive bladder cancer and procarbazine for Hodgkin’s disease. In addition, Gelclair® is for the management of oral mucositis, most commonly seen as a side effect of chemotherapy and localised radiotherapy treatement.
 

  • Medicine
  • Cosmetics
  • Medical device
  • Biocide
Showing 2 products
Gelclair

polyvinylpyrrolidone & sodium hyaluronate

Procarbazine

procarbazine hydrochloride

Share

Adverse events (side effects) thought to have been caused by one of our products should be reported to the MHRA via their yellow card scheme and to Alliance’s Pharmacovigilance team. Click here to submit a report